NEW YORK ( TheStreet) -- Cubist Pharmaceuticals (Nasdaq: CBST) hit a new 52-week high Friday as it is currently trading at $43.51, above its previous 52-week high of $43.34 with 115,347 shares traded as of 10:09 a.m. ET. Average volume has been 798,900 shares over the past 30 days. Cubist has a market cap of $2.41 billion and is part of the health care sector and drugs industry. Shares are up 7.6% year to date as of the close of trading on Thursday. Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company has a P/E ratio of 80, above the average drugs industry P/E ratio of 75.2 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter